Japan
· Delayed Price · Currency is JPY EnBio Holdings Statistics
Total Valuation
EnBio Holdings has a market cap or net worth of JPY 4.99 billion. The enterprise value is 11.88 billion.
| Market Cap | 4.99B |
| Enterprise Value | 11.88B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
EnBio Holdings has 8.10 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 8.10M |
| Shares Outstanding | 8.10M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 19.62% |
| Owned by Institutions (%) | 5.06% |
| Float | 3.67M |
Valuation Ratios
The trailing PE ratio is 11.02.
| PE Ratio | 11.02 |
| Forward PE | n/a |
| PS Ratio | 0.47 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 227.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.83, with an EV/FCF ratio of -8.25.
| EV / Earnings | 26.25 |
| EV / Sales | 1.11 |
| EV / EBITDA | 8.83 |
| EV / EBIT | 14.02 |
| EV / FCF | -8.25 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 1.09.
| Current Ratio | 1.86 |
| Quick Ratio | 1.17 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | 7.50 |
| Debt / FCF | -7.01 |
| Interest Coverage | 6.00 |
Financial Efficiency
Return on equity (ROE) is 4.72% and return on invested capital (ROIC) is 2.90%.
| Return on Equity (ROE) | 4.72% |
| Return on Assets (ROA) | 2.62% |
| Return on Invested Capital (ROIC) | 2.90% |
| Return on Capital Employed (ROCE) | 5.18% |
| Revenue Per Employee | 102.58M |
| Profits Per Employee | 4.35M |
| Employee Count | 104 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.74 |
Taxes
In the past 12 months, EnBio Holdings has paid 281.90 million in taxes.
| Income Tax | 281.90M |
| Effective Tax Rate | 40.15% |
Stock Price Statistics
The stock price has increased by +2.51% in the last 52 weeks. The beta is 0.78, so EnBio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +2.51% |
| 50-Day Moving Average | 584.44 |
| 200-Day Moving Average | 597.60 |
| Relative Strength Index (RSI) | 53.35 |
| Average Volume (20 Days) | 134,070 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EnBio Holdings had revenue of JPY 10.67 billion and earned 452.69 million in profits. Earnings per share was 55.90.
| Revenue | 10.67B |
| Gross Profit | 2.65B |
| Operating Income | 847.76M |
| Pretax Income | 702.12M |
| Net Income | 452.69M |
| EBITDA | 1.35B |
| EBIT | 847.76M |
| Earnings Per Share (EPS) | 55.90 |
Balance Sheet
The company has 3.29 billion in cash and 10.10 billion in debt, giving a net cash position of -6.81 billion or -840.21 per share.
| Cash & Cash Equivalents | 3.29B |
| Total Debt | 10.10B |
| Net Cash | -6.81B |
| Net Cash Per Share | -840.21 |
| Equity (Book Value) | 9.23B |
| Book Value Per Share | 1,128.54 |
| Working Capital | 4.14B |
Cash Flow
In the last 12 months, operating cash flow was 21.92 million and capital expenditures -1.46 billion, giving a free cash flow of -1.44 billion.
| Operating Cash Flow | 21.92M |
| Capital Expenditures | -1.46B |
| Free Cash Flow | -1.44B |
| FCF Per Share | -177.79 |
Margins
Gross margin is 24.87%, with operating and profit margins of 7.95% and 4.24%.
| Gross Margin | 24.87% |
| Operating Margin | 7.95% |
| Pretax Margin | 6.58% |
| Profit Margin | 4.24% |
| EBITDA Margin | 12.62% |
| EBIT Margin | 7.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 9.00, which amounts to a dividend yield of 1.47%.
| Dividend Per Share | 9.00 |
| Dividend Yield | 1.47% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.36% |
| Buyback Yield | -1.52% |
| Shareholder Yield | -0.05% |
| Earnings Yield | 9.07% |
| FCF Yield | -28.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EnBio Holdings has an Altman Z-Score of 1.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.39 |
| Piotroski F-Score | 4 |